Vitamin D supplement — Competitive Intelligence Brief

Vitamin D supplement (Vitamin D supplement) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin/Nutritional supplement. Area: Nutritional/Metabolic; Immunology.

marketed Vitamin/Nutritional supplement Vitamin D receptor (VDR) Nutritional/Metabolic; Immunology Small molecule

Target snapshot

Vitamin D supplement (Vitamin D supplement) — Aga Khan University. Vitamin D acts as a steroid hormone precursor that regulates calcium and phosphate homeostasis and modulates immune function.

Comparator set (5 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Vitamin D supplement TARGET	Vitamin D supplement	Aga Khan University	marketed	Vitamin/Nutritional supplement	Vitamin D receptor (VDR)
Daily Vitamin D3	Daily Vitamin D3	Medical University of South Carolina	marketed	Vitamin/nutritional supplement	Vitamin D receptor (VDR)
Vitamin D3 as "BABY D3"	Vitamin D3 as "BABY D3"	Rambam Health Care Campus	marketed	Vitamin/Nutritional supplement	Vitamin D receptor (VDR)
Vitamin D pill supplementation	Vitamin D pill supplementation	CHU de Quebec-Universite Laval	marketed	Vitamin/nutritional supplement	Vitamin D receptor (VDR)
Liquid Vitamin D	Liquid Vitamin D	University of California, San Francisco	marketed	Vitamin/nutritional supplement	Vitamin D receptor (VDR)
Placebo capsule (Vitamin K1)	Placebo capsule (Vitamin K1)	University of Sydney	phase 3	Vitamin/Nutritional supplement	Gamma-glutamyl carboxylase (GGCX)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin/Nutritional supplement class)

1. Aga Khan University · 1 drug in this class
2. Rambam Health Care Campus · 1 drug in this class
3. University of Sydney · 1 drug in this class